Lenvatinib in severe hypoglycemia associated with hepatocellular carcinoma

dc.contributor.authorGomez Torres, Katherine Milagros
dc.contributor.authorMolina Villalba, Carmen
dc.contributor.authorEstevez Escobar, Matias
dc.contributor.authoraffiliation[Gomez Torres, Katherine Milagros] Hosp Poniente el Ejido, Dept Gastroenterol, Almeria, Spain
dc.contributor.authoraffiliation[Molina Villalba, Carmen] Hosp Poniente el Ejido, Dept Gastroenterol, Almeria, Spain
dc.contributor.authoraffiliation[Estevez Escobar, Matias] Hosp Poniente el Ejido, Dept Gastroenterol, Almeria, Spain
dc.date.accessioned2025-01-07T12:40:58Z
dc.date.available2025-01-07T12:40:58Z
dc.date.issued2021-01-01
dc.identifier.doi10.17235/reed.2021.8016/2021
dc.identifier.essn2340-4167
dc.identifier.issn1130-0108
dc.identifier.pmid33947193
dc.identifier.unpaywallURLhttps://online.reed.es/DOI/PDF/ArticuloDOI_8016.pdf
dc.identifier.urihttps://hdl.handle.net/10668/24840
dc.identifier.wosID716153100015
dc.issue.number11
dc.journal.titleRevista espanola de enfermedades digestivas
dc.journal.titleabbreviationRev. esp. enferm. dig.
dc.language.isoen
dc.organizationSAS - Hospital de Poniente
dc.page.number799-799
dc.publisherAran ediciones, s a
dc.rights.accessRightsopen access
dc.subjectHypoglycemia
dc.subjectNon-islet cell tumor
dc.subjectHepatocellular carcinoma
dc.subjectIGF-2
dc.subjectLenvatinib
dc.titleLenvatinib in severe hypoglycemia associated with hepatocellular carcinoma
dc.typeletter
dc.type.hasVersionVoR
dc.volume.number113
dc.wostypeLetter

Files